Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Bass

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Gastroenterology|September 16, 2017
Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/AutoimmunityMohamad El-Zaatari, Adam J Bass, Reanne Bowlby, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2012
Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinomaLin Lin, Adam J Bass, William W Lockwood, et al.
Nature Communications|January 7, 2017
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Gabrielle Wong, et al.
Scientific Reports|August 20, 2016
Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironmentPatrick H Lizotte, Robert E Jones, Lauren Keogh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
<i>BRCA1/Trp53</i> heterozygosity and replication stress drive esophageal cancer development in a mouse modelYe He, Joshua Rivera, Miklos Diossy, et al.
Molecular Cancer|June 3, 2014
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature reviewYu Imamura, Paul Lochhead, Mai Yamauchi, et al.
Gastroenterology|April 3, 2018
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or AdenocarcinomaMatthew D Stachler, Nicholas D Camarda, Christopher Deitrick, et al.
Nature Communications|December 9, 2021
A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancerYanli Liu, Zhong Wu, Jin Zhou, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Gastroenterology|September 16, 2017
Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/AutoimmunityMohamad El-Zaatari, Adam J Bass, Reanne Bowlby, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancerTheresia Wilbertz, Patrick Wagner, Karen Petersen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2012
Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinomaLin Lin, Adam J Bass, William W Lockwood, et al.
Nature Communications|January 7, 2017
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Gabrielle Wong, et al.
Scientific Reports|August 20, 2016
Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironmentPatrick H Lizotte, Robert E Jones, Lauren Keogh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
<i>BRCA1/Trp53</i> heterozygosity and replication stress drive esophageal cancer development in a mouse modelYe He, Joshua Rivera, Miklos Diossy, et al.
Molecular Cancer|June 3, 2014
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature reviewYu Imamura, Paul Lochhead, Mai Yamauchi, et al.
Gastroenterology|April 3, 2018
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or AdenocarcinomaMatthew D Stachler, Nicholas D Camarda, Christopher Deitrick, et al.
Nature Communications|December 9, 2021
A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancerYanli Liu, Zhong Wu, Jin Zhou, et al.
Pageof 13